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ABSTRACT Thestructure,assembly,andfunctionofthebacterialﬂagelluminvolvesabout60differentproteins,manyofwhich
areselectivelysecretedviaaspeciﬁctypeIIIsecretionsystem(T3SS)(J.Fryeetal.,J.Bacteriol.188:2233–2243,2006).TheT3SSis
reportedtosecreteproteinsatratesofupto10,000aminoacidresiduespersecond.Inthiswork,weshowedthattheﬂagellar
T3SS of Salmonella enterica serovar Typhimurium could be manipulated to export recombinant nonﬂagellar proteins through
theﬂagellumandintothesurroundingmedium.Wetranslationallyfusedvariousneuroactivepeptidesandproteinsfromsnails,
spiders,snakes,seaanemone,andbacteriatotheﬂagellarsecretionsubstrateFlgM.Wefoundthatalltestedpeptidesofvarious
sizesweresecretedviathebacterialﬂagellarT3SS.Wesubsequentlypuriﬁedtherecombinant -conotoxinSIIIA(rSIIIA)from
Conus striatus by afﬁnity chromatography and conﬁrmed that T3SS-derived rSIIIA inhibited mammalian voltage-gated sodium
channelNaV1.2comparablytochemicallysynthesizedSIIIA.
IMPORTANCE Manipulationoftheﬂagellarsecretionsystembypassestheproblemsofinclusionbodyformationandcellulardeg-
radationthatoccurduringconventionalrecombinantproteinexpression.Thisworkservesasaproofofprinciplefortheuseof
engineeredbacterialcellsforrapidpuriﬁcationofrecombinantneuroactivepeptidesandproteinsbyexploitingsecretionviathe
well-characterizedﬂagellartypeIIIsecretionsystem.
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A
lthough large strides have been made in the recombinant ex-
pressionofproteins,theefﬁcientexpressionofcertainclasses
of proteins remains a challenge. These include the small, highly
stable pharmacologically active polypeptides with a high density
of disulﬁde cross links. A major group within this general class
includes the polypeptides present in animal venoms. Although
severaldifferentphylogeneticlineageshaveevolvedvenomsinde-
pendently, all polypeptides found have convergently evolved a
common set of properties that allow them to be exceptionally
stable upon injection into another organism. These polypeptides
are of increasing interest, because many of them have novel phar-
macological activity and therefore serve as useful ligands in basic
research or have direct diagnostic and therapeutic applications.
Furthermore, in contrast to some neuroactive toxins, such as te-
trodotoxin or saxitoxin, conopeptides do not pass the gut, thus
minimizing potential toxicity. Conopeptides also have a medical
advantage in that they are similar to endogenous peptide ligands
(enkephalins) that lack addictive properties compared to other
receptor-binding ligands that are addictive, such as heroin or
morphine. One of these peptides, MVIIA, a 25-amino-acid pep-
tide with three disulﬁde bonds, has become an approved drug for
intractable pain (1–3).
When recombinant expression of small disulﬁde-rich poly-
peptidesisattempted,theyieldsaregenerallylow.Afundamental
problemisthatwhenexpressionlevelsarehigh,theresultinghigh
concentrations of polypeptide in the cell lead to the formation of
intermolecular aggregates, and recombinant polypeptides are
found mostly in inclusion bodies. The ability to recover the poly-
peptidefromaninclusionbodyinabiologicallyactiveformisnot
predictable and requires additional steps that vary depending on
the polypeptide expressed.
In this work, we initiated a new approach that uses an expres-
sion system that should, in theory, bypass the inclusion body
problem of recombinant small peptide expression. It exploits the
ﬂagellarsecretionsystemofSalmonellaentericaserovarTyphimu-
rium (reviewed in references 4 and 5) that has been shown to
export nonﬂagellar proteins if fused to ﬂagellar secretion signals,
e.g.,hookproteinFlgE(6)orﬂagellinFliC(7).Theﬂagellarsecre-
tion system is a member of a family of bacterial type III secretion
systemsthatselectivelysecreteproteinsfromthecytoplasmtothe
external medium. Almost all type III secretion systems character-
ized thus far are either required for the secretion of virulence de-
terminantsforanumberofplantandanimalpathogensorforthe
secretionofproteinsrequiredforthestructureandfunctionofthe
bacterial ﬂagellum. About 60 genes are involved in assembly and
regulation of the bacterial ﬂagellum (8). The overall structure is
composed of an external helical ﬁlament, extending many body
lengthsfromthecellsurface,attachedtoarotarymotorembedded
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sorysystemcontrolstheclockwiseandcounterclockwisedirection
ofﬂagellarrotation,whichallowsthebacteriumtomigratetoward
attractants, such as nutrients, or away from repellents that are
harmful to the bacterium.
The speciﬁcity for ﬂagellar substrate secretion is primarily de-
termined by an N-terminal peptide secretion signal that has a
disorderedstructure.Manysecretionsubstratesalsorequireaspe-
ciﬁc secretion chaperone to facilitate secretion. One ﬂagellar se-
cretionsubstrate,FlgM,isaregulatoryproteinthatcouplesﬂagel-
lar assembly to gene expression (9–12). 28, a transcription factor
speciﬁcforﬂagellarpromoters,directstranscriptionofgenesspe-
ciﬁcally needed after completion of the ﬂagellar hook-basal body
structure (HBB) and thereby induces expression of the ﬁlament
and chemosensory genes. FlgM binds 28 and prevents its associ-
ation with RNA polymerase. Completion of the ﬂagellar hook
resultsinachangeinsubstratespeciﬁcityoftheﬂagellarsecretion
apparatus, switching from secretion of proteins required for
hook-basal body assembly to late substrate secretion of proteins
needed in ﬁlament assembly. FlgM itself is a late secretion sub-
strate and its secretion releases 28, enabling it to transcribe the
ﬁlament and chemosensory genes only upon completion of the
HBB(11,13).Atthesametime,the28transcriptionfactoractsas
the secretion chaperone that facilitates the secretion of its inhibi-
tor, FlgM (14).
In this work, we utilized the ﬂagellar FlgM protein as a vector
for the secretion of the small, highly stable pharmacologically ac-
tive polypeptides that contain a high density of cysteine residues,
whichformdisulﬁdecross-linksinthematureproduct.Asaproof
of principle, we engineered a bacterial secretion system for the
recombinant expression of -conotoxin SIIIA in Salmonella Ty-
phimurium.UsingtheﬂagellartypeIIIsecretion(T3S)apparatus,
therecombinantconopeptidewasselectivelysecretedintothecul-
ture medium (Fig. 1).
RESULTS AND DISCUSSION
Conopeptides are synthesized in the venom duct of marine cone
snails and target ion channels, including voltage-gated sodium
channels (VGSCs) (15). SIIIA is a -conotoxin from Conus stria-
tus that inhibits tetrodotoxin (TTX)-resistant VGSCs in frog (16)
and TTX-sensitive VGSCs in rodents (17). The -conotoxin
SIIIA binds to site 1 of the -subunit of VGSCs (18–20) and
thereby occludes the channel pore and blocks sodium conduc-
tance. Under physiological conditions, two forms of SIIIA exist,
a precursor form and a mature peptide, which has been modiﬁed
by processing the C-terminal glycine-arginine residues to an
amino group and changing the N-terminal glutamine residue to
pyroglutamate. In this work, we recombinantly expressed two
forms of SIIIA, the precursor peptide and a peptide that most
closely resembles the physiological mature form (N-terminal glu-
tamate instead of pyroglutamate). In mammalian preparations,
-SIIIA effectively blocks neuronal sodium channels, such as
NaV1.2 and NaV1.6, and the skeletal muscle subtype NaV1.4 (17).
Because SIIIA targets VGSCs and has potent analgesic activity in
mice (21), it is a promising peptide for medical research and drug
discovery (22). The fundamental advantage in developing our
T3SSbacterialexpressionsystemisthataftertranslationthepoly-
peptides translocate through a narrow secretion channel in the
ﬂagellar structure and thereby bypass the problem of aggregation
in inclusion bodies. Polypeptide secretion should prevent inter-
molecular aggregation in the cytoplasm. Intramolecular disulﬁde
bonds should form as the polypeptide chain exits the reductive
environment of the bacterial cytoplasm and enters an oxidizing
extracellular environment.
We focused on assessing how efﬁciently different constructs
serve as type III secretion substrates. The SIIIA pretoxin (-
SIIIApreinTable1andhenceforthreferredtoasrSIIIA)isasmall
22-amino-acid peptide which was fused to FlgM with an
N-terminal TEV cleavage site in front of SIIIA. In order to ensure
proper secretion and to diminish the possibility of interference
with the structural secretion signal of FlgM, three different con-
structs were designed with a polyhistidine tag at different posi-
tions. All constructs were chromosomally expressed from the
arabinose-induciblepromoterParaBAD.Figure1bshowsthesecre-
tion proﬁle of all three constructs. Construct 3 (FlgM-H6-TEV-S
IIIA) displayed the most prominent secretion product; construct
2(FlgM-TEV-SIIIA-H6)exhibitedthelowestsecretionlevel.This
secretion ranking was consistent in all backgrounds tested, some
ofwhichcarriedamutation(ﬂiA*,withtheasteriskindicatingthe
mutation [H14D]) in the 28 structural gene ﬂiA that enhances
stabilityofthisFlgMsecretionchaperoneprotein(9).Asexpected,
FlgM levels were very low in a strain unable to form a ﬂagellar
structure (ﬂiF strain) compared to those in a wild-type strain.
The ﬂagellum-speciﬁc transcription factor 28 acts as a chap-
erone to facilitate FlgM secretion. As shown in Fig. 1c, 28 H14D,
with its enhanced stability (10), increased levels of intracellular
and secreted FlgM-SIIIA. 28 H41D also increases FlgM stability
(14). This is the likely cause of the increased levels of FlgM-SIIIA
intheﬂiA*background(Fig.1c,lanes2and3).Wealsotestedthe
effect of removing the late ﬂagellar secretion substrates (and po-
tential secretion competitors) FliC and FliD (ﬂiCD). The ﬂiC
andﬂiDgenesaredivergentlytranscribed.However,theﬂiDgene
is in an operon with ﬂiT, which encodes the FliT inhibitor of all
ﬂagellar gene expression. Thus, the ﬂiCD deletion results in re-
movalofsecretioncompetitorsforFlgMinadditiontoincreasing
the number of ﬂagellar basal structures (11). The net effect was
increasedproductionandsecretionofbothFlgMandFlgM-SIIIA
from the cell (Fig. 1c, lanes 2 and 4).
As FlgM-H6-TEV-SIIIA showed the highest level of secretion,
this construct was used for further puriﬁcation experiments. The
SIIIAfusionwasexpressedfromanarabinose-induciblepromoter
toallowsynchronizationofthehighlevelofexpressionwithcom-
pletionoftheﬂagellarsecretionsystems.SecretedFlgM-H6-TEV-
SIIIA was separated from the bacterial cell culture by centrifuga-
tion and was obtained from the supernatant under native
conditions by nickel-afﬁnity chromatography. As shown in
Fig. 2a, FlgM-H6-TEV-SIIIA efﬁciently bound to the Ni-IDA res-
insandwaselutedwithimidazole-containingelutionbuffer.After
concentration of the eluted fraction, rSIIIA was cleaved from the
FlgM-H6-TEV secretion signal using TEV protease. Western blot
analysis and Coomassie staining demonstrated that TEV cleavage
was complete after3ha troom temperature (data not shown).
As with all cysteine-rich peptides, the formation of the native
disulﬁde bonds is a crucial process in generating biologically ac-
tive SIIIA. However, the optimal buffer conditions of the TEV
protease require 1 mM dithiothreitol (DTT). This redox agent
provides reducing power for the TEV protease but at the same
time should reduce S-S bonds in the peptide of interest. For this
reason, we decided to refold rSIIIA prior to electrophysiological
analysis. Refolding was carried out in a redox buffer of oxidized
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® mbio.asm.org May/June 2012 Volume 3 Issue 3 e00115-12FIG 1 Engineering the ﬂagellar type III secretion system for the secretion of SIIIA conotoxins. (a) Model: An FlgM-SIIIA translational fusion is a secretion
substrateofthebacterialT3SS.Thefusionconstructissecretedviatheﬂagellum-speciﬁcT3SSthroughtheﬂagellarchannelintotheculturemediumviaﬂagellar
structures that are competent for FlgM secretion. Expression of FlgM-SIIIA is induced upon addition of arabinose and is independent of ﬂagellar class I and II
gene expression. During HBB assembly, FlgM remains inside the cytosol and acts as an anti-28 factor preventing transcription of class III genes, e.g., genes
encodingtheﬂagellinsubunitFliCorthestatorproteinsMotAandMotB.TheHBBstructureiscompletedwithin30min(39),whichcoincideswithasubstrate
speciﬁcity switch within the ﬂagellar secretion apparatus (indicated by an orange asterisk in the ﬁgure) from early to late substrate secretion. This results in
secretionofFlgMandsubstratesneededduringtheﬁnalphaseofﬂagellumassembly.OM,outermembrane;PG,peptidoglycanlayer;IM,innermembrane.(b)
ExpressionandsecretionoftheFlgM-SIIIAfusionprotein.SecretedFlgM-SIIIAwasprecipitatedusingTCA,andimmunoblotswithantibodiesagainstFlgMare
shownforcellularandsupernatantfractions.ProteinbandsofnativeFlgM(o)andFlgM-SIIIA(‘)fusionsaremarkednexttotheblot.Constructs1to3(labeled
c1toc3)representthefollowingproteinfusions:c1H6-FlgM-TEV-SIIIA,c2FlgM-TEV-SIIIA-H6,c3FlgM-H6-TEV-SIIIA.Secretionefﬁcienciesofthree
FlgM-SIIIA constructs varying in their position of the polyhistidine tag were tested. Secretion levels are shown for TH437 (wt, lane 1), TH4885 (ﬂiF, lane 2),
TH5139(ﬂgM,lane3),TH10874(Para::ﬂgM,lane4),TH15705(ﬂiA*Para::c1,lane5),TH15706(ﬂiA*Para::c2,lane6),andTH15707(ﬂiA*Para::c3,lane7).
Wild-type FlgM bands in lanes 5 to 7 were visible upon extended exposure. (c) FlgM-H6-TEV-SIIIA was expressed from the arabinose promoter, and secretion
wascomparedinﬂiAwt(lane2),ﬂiA*(H14D,lane3),andﬂiCD(lane4)backgrounds.Secretionofwild-typeFlgMexpressedfromitsnativepromoterisshown
in lane 1 (TH437, labeled wt).
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tions under conditions that are known to favor formation of the
native disulﬁde bonds (16).
TestsoftherSIIIAprecursorformonXenopusoocytesexpress-
ing rat NaV1.2 demonstrated that its functional activity was simi-
lar to that of chemically synthesized SIIIA. Sodium currents in
response to depolarization were recorded as described in Materi-
als and Methods. Figure 2b presents the results from a represen-
tative experiment in which rSIIIA blocked NaV1.2 conductance
(compare the peak current of the oocyte before [gray trace] and
after [black trace] rSIIIA exposure). The kinetics of the onset of
block following exposure to 10 M rSIIIA and the recovery from
blockfollowingitswashoutwereassessedasdescribedinMaterials
and Methods. The observed rate constant for the onset of block
(kobs) and the rate constant for recovery from block (koff) were,
respectively, 0.17  0.04 min1 and 0.0043  0.0004 min1
(meanstandarddeviation[SD];n3oocytes).Thekoffvalueis
closetothatobservedwithchemicallysynthesizedSIIIA;however,
thekobsvalueisabout6-foldlowerthanthatobservedwithchem-
icallysynthesizedSIIIA(17).Thedifferenceinkobsisthoughttobe
due to the disparity in the sequences of the two peptides (N-
terminal glycine carryover after TEV cleavage and lacking post-
translational modiﬁcations), and experiments are under way to
test this assumption.
In addition to the secretion of SIIIA pretoxin, several other
peptides from various organisms, such as spider (GsMTx4), scor-
pion (chlorotoxin), snake (calciseptine), snails (-MVIIA,
-GVIA, contulakin-G, -Vc1.1, conantokin-G, mature SIIIA),
and sea anemone (Shk) were tested for recombinant expression
and subsequent secretion in a complementary approach (see Ta-
ble1foradetailedlist).Althoughthereweredifferencesincellular
levels and secretion efﬁciencies, the results shown in Fig. 2c dem-
onstrate that all tested peptides were secreted into the culture su-
pernatant.Wealsotestedthesecretionoftheunstable190-amino-
acid-long catalytic subunit of diphtheria toxin fused to FlgM
(Fig. 2d). Notably, the proteolytic degradation that was observed
within the cytosolic fraction did not occur once the protein was
secreted from the cell.
For further optimization of the Salmonella secretion strain, a
nonmotilepolyhookmutantwasconstructedthathadthefollow-
ing characteristics. It lacked the ﬂagellum-related SPI-1 (prgH-
hilA)virulencesystem,aswellasallclass3ﬂagellargenes(ﬂgKL,
ﬂjB-T, ﬂgMN, aer-mcpC,P motA, motA-cheZ, mcpA,
mcpB, tsr) that could diminish or interfere with ﬂagellar type
III secretion of the toxin fusion of interest. In addition, the strain
harbored a mutation in the ﬂhD promoter (P*ﬂhD) and was de-
leted for negative regulators of the ﬂagellar master regulator
FlhD4C2(lrhA,ydiV,ecnR).LrhAactsasanegativeregulator
of ﬂhDC transcription by directly binding to the promoter region
of the master regulator (23). The EAL domain protein YdiV post-
translationally regulates the activity of the FlhD4C2 protein by
targeting the complex for ClpXP-dependent degradation and
thereby negatively inﬂuences FlhDC-dependent ﬂagellar class 2
promoter activity (24, 40). Transposon insertions in those nega-
tive regulators of FlhDC have been shown to increase ﬂagellar
gene expression (25, 26).
As shown by ﬂuorescent labeling of the ﬂagellar hook struc-
tures in Fig. 3a, these mutations resulted in a roughly 2-fold in-
crease of ﬂagellar secretion structures per cell compared to wild-
type cells, which in turn led to a substantial increase in the
secretion rate of ﬂagellar proteins. Secretion rates of FliK and
FlgM-SIIIA (construct 3) were roughly 2-fold higher in the poly-
hook background than in the wild-type and ﬂiA* backgrounds
(Fig. 3b).
The major advantage of this system is the workﬂow. After in-
duction with arabinose, the bacterial cells express recombinant
polypeptidesandsubsequentlysecretethetoxinintothemedium.
Contrarytothepuriﬁcationofneuropeptidebytraditionalmeth-
ods (27), this makes it unnecessary to lyse cells in order to purify
peptides. Instead, recombinant SIIIA was selectively secreted via
the ﬂagellar T3SS and it accumulated in the culture supernatant.
After several hours of production, cells were removed by simple
centrifugation and ﬁltration. Other important aspects of this sys-
tem are type III secretion chaperones that facilitate secretion or
increasethestabilityofthesecretionsubstrates.TypeIIIsecretion
substrates are usually secreted in an unfolded or partially folded
TABLE 1 Peptides used in this study
Peptide name Organism Species Peptide size (aa) Amino acid sequence (without modiﬁcations)
-MVIIA Cone snail Conus magus 25 CKGKGAKCSRLMYDCCTGSCRSGKC
-GVIA Cone snail Conus geographus 27 CKSPGSSCSPTSYNCCRSCNPYTKRCY
Contulakin-G Cone snail Conus geographus 16 ESEEGGSNATKKPYIL
-Vc1.1 Cone snail Conus victoriae 16 GCCSDPRCNYDHPEIC
Conantokin-G Cone snail Conus geographus 17 GEEELQENQELIREKSN
-SIIIAmat Cone snail Conus striatus 20 ENCCNGGCSSKWCRDHARCC
-SIIIApre Cone snail Conus striatus 22 QNCCNGGCSSKWCRDHARCCGR
Shk Sea anemone Stichodactyla helianthus 35 RSCIDTIPKSRCTAFQCKHSMKYRLSFCRKTCGTC
Chlorotoxin Scorpion Leiurus quinquestriatus 36 MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR
GsMTx4 Spider Grammostola spatulata 35 GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSSG
Calciseptine Snake Dendroaspis polylepis polylepis 60 RICYIHKASLPRATKTCVENTCYKM
FIRTQREYISERGCGCPTAMWPYQTECCKGDRCNK
DTA Y65A Bacterium Corynebacterium diphtheriae 190 GADDVVDSSKSFVMENFSSYHGTKPGYVDSIQK
GIQKPKSGTQGNYDDDWKGFYSTDNKYDAAGASV
DNENPLSGKAGGVVKVTYPGLTKVLALKVDNAE
TIKKELGLSLTEPLMEQVGTEEFIKR
FGDGASRVVLSLPFAEGSSSVEYINN
WEQAKALSVELEINFETRGKRGQDAMYEYMAQACAGNR
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with the secondary structure of the secreted protein. Since SIIIA
was fused to FlgM, a type III secretion substrate, it was likely pro-
tected from premature folding by interaction with FliA (28), the
cognate type III secretion chaperone of FlgM (14). In the past,
shorter fragments of FliC containing only the presumed type III
secretion signal were used as a secretion shuttle (7). For our re-
combinant expression, we intentionally used full-length FlgM,
whichincreasedsecretionefﬁciencyduetothepresenceofitsFliA
chaperone-binding site.
In summary, this system provides an easy-to-use method
for complicated peptide puriﬁcation—a task that goes beyond
yield and solubility of peptides and requires the peptides and
proteins to be accessible in a correctly folded and active state.
As shown here, this technique could be of use for the diverse
array of different bioactive small peptides that is especially ap-
parent within the venom of cone snails. More than 500 species
ofﬁsh-,mollusk-,andworm-huntingconesnailshaveevolved,
and every Conus species appears to have a repertoire of around
100 different venom components, mostly small, disulﬁde-rich
peptides that rapidly affect the prey organism at multiple tar-
gets. Each neuroactive peptide of the venom is highly speciﬁc
for an individual channel isoform, and it is estimated that
50,000conopeptidesexist,butlessthan0.1%havebeenchar-
acterized pharmacologically (22, 28). To make use of this po-
tential, it is necessary to isolate and characterize the target and
mode of action of single venom components. The identiﬁca-
tionofneuroactiveligandshasapotentialtomakeasigniﬁcant
contribution to understanding the molecular basis of electrical
signaling in the nervous system of mammals. Additionally, in-
dividual peptides come into consideration as potential phar-
maceuticalagents—asanalgesicsandasdrugsforthetreatment
of various diseases such as epilepsy, autoimmune diseases, or
even spinal cord injuries.
FIG 2 Puriﬁcation and electrophysiology of recombinant conotoxin SIIIA and secretion of toxins from various organisms via the ﬂagellar T3SS. (a) The
supernatantofastrainexpressingandsecretingrecombinantSIIIAfusedtoFlgM(TH15707ﬂiA*[H14D]araBAD1036::ﬂgM-H6-TEV-SIIIA)wasﬁlteredand
bound to an Ni2-IDA column as described in Materials and Methods. The matrix was washed after binding (W1 to W3), and FlgM-SIIIA was eluted in three
steps with imidazole-containing elution buffer (E1 to E3). For Western blot detection, samples were TCA precipitated. Due to the increased FlgM-SIIIA
concentration in the elution fractions, only 1/10 of the volume was used for TCA precipitation of elution fractions 1 to 3. (b) Recombinant SIIIA blocks
voltage-gatedsodiumchannelNaV1.2.AXenopusoocyteexpressingratNaV1.2wasexposedto10MrSIIIA,whilesodiumcurrentsweremonitoredasdescribed
in Materials and Methods. Currents recorded before toxin exposure (control, gray trace) and following ~20-min exposure to 10 M rSIIIA (black trace). Each
tracerepresentstheaverageofﬁveresponses.ThedifferenceofthepeakvaluesbetweenthetwotracescorrespondstotheinhibitoryeffectrSIIIAhasonchannel
NaV1.2.FlgM-H6-TEVwastranslationallyfusedtosixdifferentpeptidesfromconesnailsandonepeptideeachfromaseaanemone,scorpion,spider,andsnake
(c),andFlgM-H6wasfusedtoCorynebacteriumdiphtheriae(d)(seealsoTable1foradetailedlist).PeptideswereexpressedinaSalmonellapolyhookbackground
(seetextfordetails).SecretionofdiphtheriatoxinfragmentAfromSalmonellastrainTH16229wastestedusingthreeindependentbiologicalreplicates(labeled
1 to 3). Secretion of recombinant peptides was performed as described before.
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® mbio.asm.org 5FIG 3 Effect of Salmonella polyhook background on secretion. (a) Immunostaining of the polyhook background TH16778 used for secretion of FlgM-H6-
TEV-toxin fusions. A three-fold repeat of a hemagglutinin epitope tag was inserted into the ﬂagellar hook subunit to facilitate hook detection by ﬂuorescent
microscopy. Red, membrane stained with FM-64; blue, DNA stained with Hoechst; green, ﬂagellar hook-basal-body complexes (ﬂgE::3HA) labeled with
antihemagglutinin antibodies coupled to Alexa Fluor 488. The scale bar is 5 m. (b) Secreted proteins were precipitated using TCA, and immunoblots with
antibodiesagainstFlgMandFliKareshownforcellularandsupernatantfractions.ProteinbandsofnativeFlgM(o)andFlgM-SIIIAfusions(‘)aremarkednext
to the blot. Secretion levels were compared by measuring the densiometric intensity of the detected bands using ImageJ (37). Secretion values relative to the
secretion in a Para wild-type background (ﬁrst lane) are displayed below the corresponding band.
Singer et al.
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Bacterial strains and media. All bacterial strains used in this study are
listedinTableS1inthesupplementalmaterial.Thecommonlyusednon-
pathogenic strain of Salmonella enterica serovar Typhimurium LT2 was
used for all experiments. LT2 harbors mutations in the ropS and mviA
genes that render it avirulent (29–31). The mviA gene encodes for the
regulator of a two-component system involved in Salmonella virulence.
The rpoS gene product (stationary-phase sigma transcription factor) is
required for the expression of multiple virulence factors. The two muta-
tions within the virulence pathway of Salmonella result in attenuation of
virulence. To further ensure nonpathogenicity of the used bacterial ex-
pression strains, most experiments were performed in a strain deleted for
major structural parts and the master regulator of the SPI-1 injectisome
virulence system (prgH-hilA).
Cells were cultured in Luria-Bertani (LB) medium and, when neces-
sary, supplemented with ampicillin (100 g/milliliter) or tetracycline
(15 g/milliliter). The generalized transducing phage ofS. Typhimurium
P22 HT105/1 int-201 was used in all transductional crosses (32).
All work regarding Salmonella Typhimurium was performed with in-
stitutionalapproval,andinparticularworkwithpuriﬁedconotoxinSIIIA
was performed under select agent rules at the University of Utah.
Construction of chromosomally expressed ﬂgM-toxin fusions.
SIIIA was ampliﬁed with a de novo ﬁll-in PCR reaction using a long
primer, SIIIA_long_fw (CAGAACTGCTGCAACGGCGGCTGCAGCAG
CAAATGGTGCCGCGATCATGCGCGCTGCTGCGGCCGC), covering
all 66 bp encoding SIIIA (QNCCNGGCSSKWCRDHARCCGR). The
SIIIA sequence was designed according to the optimal codon usage of
Salmonella Typhimurium. The 66-bp sequence was duplexed with the
help of a short reverse primer (SIIIA_short_rv: GCGGCCGCAGCAGCG
CGCATG) initiating the ﬁll-in from the 3= end of the template primer.
A cleavage site for the TEV protease (ENLYFQG) and a polyhistidine
tag [H6 encoded by (CATCAC)3, indicating a triple repeat of two codons
encoding the same 6 amino acids] were inserted during ampliﬁcation of
ﬂgM and SIIIA at various positions, resulting in three different construct
(named constructs 1 to 3).
Below, the construction procedure of construct 1 will be explained
exemplarilyinmoredetail,andconstruct2andconstruct3weredesigned
accordingly (see Table S2 in the supplemental material for primer se-
quences). The ﬂgM gene was ampliﬁed from genomic DNA (TH2788)
using forward primer 1_HS1_ﬂgM_fw and reverse primer
1_HS2_ﬂgM_rv.Thereverseprimerencodedan18-bpoverhangthatwas
homologous to the 5= SIIIA sequence (see above). To increase the length
ofthehomologousregion,SIIIAwasampliﬁedfromtheprevioussynthe-
sized template with primers 1_HS3_SIIIA_fw and 1_HS4_SIIIA_rv, add-
ing an additional 10-bp overlap with homology to the sequence of the
TEV protease cleavage site. The PCR products of FlgM and SIIIA were
puriﬁed and used in a subsequent fusion PCR as a template together with
forward primer 1_HS1_ﬂgM_fw and reverse primer 1_HS4_SIIIA_rv.
ThismethodallowsthefusionoftwoPCRproductsthatshareahomology
of (in case of construct 1) 28 bp, resulting in one long ﬂgM-SIIIA fusion
construct.Allconstructscontaineda5=-BamHIanda3=-EcoRIrestriction
site for cloning into pUC18, resulting in the subcloning vectors (pHS1
[pUC18 BamHI-His6-ﬂgM-TEV-SIIIA-EcoRI], pHS2 [pUC18 BamHI-
ﬂgM-TEV-SIIIA-His6-EcoRI], and pHS3 [pUC18 BamHI-ﬂgM-His6-
TEV-SIIIA-EcoRI]).
All ﬂgM-SIIIA fusions were ampliﬁed from the respective subcloning
vectorswithprimershavinghomologousregionsforthenativeﬂgMlocus
or the arabinose locus (araBAD). Chromosomal insertions were con-
structed using -Red-mediated recombination as described before (33).
The expression of SIIIA in Salmonella resulted in a recombinant pep-
tidethatwaslackingposttranslationalmodiﬁcationsthatareusuallypres-
ent under physiological conditions. Those include a neutral N-terminal
pyroglutamate,C-terminalamidation,andcleavageofatwo-residuefrag-
ment named SIIIApre. However, according to functional studies on the
related -conotoxin GIIIA, the potency of SIIIA is thought to be deter-
minedbythelysineatposition11(16,34–36)andthereforeshouldnotbe
affected by any N- and C-terminal sequence variations.
Allotherpeptidesfromvariousorganisms(snails,spiders,snakes,and
sea anemone) were constructed correspondingly, and their sequences are
listed in Table 1 and Table S2 in the supplemental material.
Fragment A of the diphtheria toxin (DTA Y65A) was ampliﬁed from
plasmid pTH794 with primers DTA-ﬂgM_fw (ACTCGCTCATTCGCGA
GGCGCAGAGCTACTTACAGAGTAAAGGCAGCTCTCACCACC
ACC) and DTA-ﬂgM_rv (TTCATCAACGCGCCCCCCATGGGACGCG
TTTTTAGA GGCATTAACGGTTACCTGCACAAG). DTA ampliﬁca-
tionincludedapolyhistidinetag(H6)withaGSSlinkerbeforetheHistag
and an SSGLVPR linker between the His tag and the ﬁrst amino acid of
DTA. DTA was chromosomally inserted by -Red-mediated recombinat
ion. The insertion was carried out in a araBAD::ﬂgM background.
DTA was targeted in front of the ﬂgM stop codon, resulting in a translat
ional ﬂgM-DTA fusion.
Recombinant expression and puriﬁcation of SIIIA conotoxin.
StrainsexpressingSIIIAconotoxinfusionswerepickedfromafreshsingle
colony and grown in 10 ml LB overnight. The overnight cultures were
diluted 1:100 into 1 liter of fresh medium and grown for 6 h. If appropri-
ate,SIIIAexpressionwasinducedaftertheﬁrst2hbytheadditionof0.2%
arabinose. Cells were pelleted by centrifugation (7,000 rpm), and the su-
pernatant containing FlgM-SIIIA was passed through a 0.22-m poly-
ethersulfone ﬁlter (Corning, NY), a low-protein-binding membrane for
removal of residual bacteria. For further puriﬁcation, a gravity ﬂow col-
umn(Bio-Rad)packedwith3gNi-IDAresin(ProtinoNi-IDA;Machery-
Nagel) was used, and afﬁnity-tagged proteins were eluted under native
conditions at pH 7.5 with a buffer containing 250 mM imidazole.
Secretion assay. Overnight cultures were diluted 1:100 in LB and
grown for2ha t37°C before inducing the expression of the respective
FlgM-toxinfusionbyadding0.2%l-arabinose.Cellswerekeptat37°Cfor
anadditional4h,whilethefusionproteinswereexpressed.Afteratotalof
6 h, the optical density at 600 nm (OD600) was determined for all strains.
Two-milliliter aliquots of the resulting cell culture were centrifuged
for 10 min at 4°C and 7,000 rpm to obtain, for each aliquot, a pellet and
supernatant.Thesupernatantwasﬁlteredthroughalow-protein-binding
ﬁlterwitha0.2-mporesize(Acrodisksyringeﬁlter;PallLifeSciences)to
removetheremainingcells.Alternatively,aliquotswerecentrifugedtwice
at maximum speed to remove residual cells. Secreted proteins in the ﬁl-
tered or twice-centrifuged supernatant were precipitated by the addition
of TCA (10% ﬁnal concentration). The supernatant samples were resus-
pended in 2 SDS sample buffer (100 mM Tris [pH 6.8], 4% SDS, 10%
glycerol, 2% -mercaptoethanol, 25 mM EDTA, 0.04% bromophenol
blue) and adjusted to 20 OD600 units/l. The cellular pellet fraction was
suspended in 2 SDS sample buffer, whose volume was adjusted to yield
20 OD600 units/l.
SDS-PAGE and Western blotting. Expressed FlgM-toxin fusions of
whole-cell lysate and cultural supernatant were subjected to SDS poly-
acrylamide gel electrophoresis and analyzed by immunoblotting using
polyclonal anti-FlgM and polyclonal anti-FliK antibodies (rabbit) for de-
tection. Antigen-antibody complexes were visualized by chemilumines-
centorinfrareddetectionusingtheLI-COROdysseyimagingsystem.For
chemiluminescent development, secondary goat -rabbit antibodies
(Bio-Rad) conjugated with horseradish peroxidase (HRP) and an ECL
detection kit (Amersham Biosciences) were used. For infrared detection,
secondary anti-rabbit IRDye690 (LI-COR) was used. Densiometric mea-
surements of FlgM-SIIIA and FliK bands were performed using ImageJ
1.45s for Mac OS X (37).
TEV protease cleavage. SIIIA was cleaved off ﬂagellar secretion sub-
strates using AcTEV protease (Invitrogen). A total of 450 uniﬁed atomic
mass units of TEV protease was added to 15 ml of the elution fraction,
whichcorrespondstothesecretedproteinsfroma750-mlculture.Cleav-
age was performed overnight at room temperature in elution buffer con-
taining 1 mM DTT and 0.5 mM EDTA.
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pH7.5,using1mMoxidizedglutathione(GSSG)and0.1mMEDTA.The
folding reaction was allowed to proceed overnight at room temperature
and was quenched by the addition of formic acid to a ﬁnal concentration
of 8%.
Solid-phase extraction of SIIIA. C18 solid-phase extraction columns
(Supelclean LC-18; Supelco) were used to remove the oxidized peptide
from the other components of the folding and cleavage reactions. The
isolated peptide was then dried and puriﬁed by high-performance liquid
chromatography(HPLC)onaWaters600chromatograph,equippedwith
a dual-wavelength absorbance detector and a Vydac C18 analytical col-
umn. The HPLC separation was run with a linear gradient from 4.5% to
31.5% aqueous (aq) acetonitrile (0.9% change per minute), maintaining
0.1% triﬂuoroacetic acid (TFA) throughout. This allowed puriﬁcation of
the correct folding product; mass was validated by matrix-assisted laser
desorption ionization--time of ﬂight mass spectrometry (MALDI-TOF).
Electrophysiology of mammalian NaV channels. The functional ac-
tivity of recombinant SIIIA was assessed electrophysiologically with Xe-
nopus oocytes expressing NaV1.2, as described before (38). Brieﬂy, the
oocyte was placed in a 30-l recording chamber perfused with ND96 and
two-electrodevoltageclamped.Aholdingpotentialof80mVwasused,
andactivationofsodiumchannelswasachievedbysteppingthepotential
to 10 mV for 50 ms every 20 s. Exposure to toxin was performed in a
static bath to conserve peptide, as follows. Prior to toxin application, the
perfusion of the bath was halted, and control responses were recorded.
Peptide (3 l at 10 times the ﬁnal concentration) was then applied to the
bath, which was stirred for 5 s using a micropipette. Recordings of the
onsetofblockbythepeptidewereobtainedforabout20min,afterwhich
the perfusion with ND96 was resumed to remove unbound peptide while
therateofrecoveryfromblockwasmonitoredforabout20min.Thetime
course of the onset of block was ﬁt to a single-exponential function to
obtaintheobservedrateconstantofblock,kobs.Therateofrecoveryfrom
blockduringpeptidewashoutwastooslowtomeasurebycurveﬁtting,so
koff was estimated from the level of recovery after 20 min of washing and
assumingexponentialdecayofblock(17).Allrecordingswereobtainedat
room temperature.
Immunostaining. Fluorescent microscopy analysis was performed as
described previously by Erhardt and Hughes (25).
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